2. UroToday Home
  3. Recent Abstracts
  4. Urologic Oncology
  5. Prostate Cancer

Age 70 +/− 5 Years and Cancer-Specific Outcomes After Treatment of Localized Prostate Cancer: A Systematic Review

A secondary analysis of 2 randomized Radiation Therapy Oncology Group trials demonstrated that age ≥70 years was a favorable prognostic factor among men treated with external beam radiation therapy (EBRT). In contrast, several series based on men undergoing radical prostatectomy (RP) suggested that older age was an unfavorable prognostic factor. Our study was initiated to determine whether these observations reflect a true but paradoxical underlying age-related treatment-dependent biological phenomenon. We conducted a systematic review (PubMed, January 1, 1999-January 30, 2023) evaluating the effect of age on cancer-specific outcomes after definitive local treatment with either RP or EBRT. Our main objective was to assess possible interactions between age (using a cutoff of 70 +/− 5 years) and treatment type, with regard to adverse cancer-specific outcomes (eg, pathology, biochemical failure, distant metastasis, or prostate cancer−specific survival). Forty-five studies were selected for inclusion in this systematic review, including 30 and 15 studies with patients treated with RP and EBRT, respectively. Among patients treated with RP, 10 (50%) of these studies suggested that older age was associated with worse outcome(s) after RP. None suggested that age was a favorable prognostic factor after RP. Among the EBRT-based studies, 8 (53%) suggested that older age was associated with better outcomes, with an additional 3 studies (21%) trending to support a better outcome. None of these studies involving EBRT suggested that older age was an adverse prognostic factor. This systematic review suggests that age using a categorical cutoff of 70 +/− 5 years may be an adverse prognostic factor for men undergoing RP but a favorable prognostic factor for men treated with EBRT. Further research is needed to validate these findings.

Haitham Shaheen, MD, Mia A. Salans, MD, MAS (Resident), Osama Mohamad, MD, PhD, Pamela W. Coleman, MD, FACS, FPMRS, Soha Ahmed, MD, MBA, and Mack Roach, III, MD, FACR, FASTRO, FASCO

Clinical Oncology, Suez Canal University Hospital, Ismailia, Egypt; Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; Department of Genitourinary Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas; Division of Urology, Department of Surgery, Howard University Hospital, Washington, DC; Clinical Oncology Department, Suez University, Suez, Egypt

Source: Shaheen H., Salans, MA., Mohamad O. et al. "Age 70 +/− 5 Years and Cancer-Specific Outcomes After Treatment of Localized Prostate Cancer: A Systematic Review." International Journal of Radiation Oncology Biology Physics. 2023. DOI: 10.1016/j.ijrobp.2023.09.018.